Skip to main content
VCbacked
Log inGet Started

FYR Diagnostics

Missoula, United States

FYR Diagnostics develops biomarker detection technology to combat chronic diseases in both human healthcare and agriculture.

$8.0M raised
Sep 2025
Venture - Series Unknown
BiotechnologyHealth CareTherapeutics

Top Investors

National Science FoundationTwo Bear CapitalYuvaan Tiwari FoundationSontag Innovation FundMike Goguen

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about FYR Diagnostics

How much funding has FYR Diagnostics raised?
FYR Diagnostics has raised $8.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2025.
Who are FYR Diagnostics's investors?
FYR Diagnostics's investors include National Science Foundation, Two Bear Capital, Yuvaan Tiwari Foundation, Sontag Innovation Fund, Mike Goguen.
Where is FYR Diagnostics headquartered?
FYR Diagnostics is headquartered in Missoula, United States.
What does FYR Diagnostics do?
FYR Diagnostics develops biomarker detection technology to combat chronic diseases in both human healthcare and agriculture.
What stage is FYR Diagnostics at?
FYR Diagnostics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"FYR Diagnostics — Funding & Investors." VCBacked, September 24, 2025, https://www.vcbacked.co/company/fyr-diagnostics. Accessed June 3, 2026.
APA
VCBacked. (2025). FYR Diagnostics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/fyr-diagnostics
Wikipedia (cite web)
{{cite web |title=FYR Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/fyr-diagnostics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong